Home / Recalls / Lowlite Investments, Inc. D/B/A Olympia Pharmacy / D-716-2013

D-716-2013 Class II Ongoing

Recalled by Lowlite Investments, Inc. D/B/A Olympia Pharmacy — Orlando, FL

Recall Details

Product Type
Drugs
Report Date
July 17, 2013
Initiation Date
May 29, 2013
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2

Product Description

Deslorelin 15 mg vial, compounded by Olympia Pharmacy, Orlando, FL

Reason for Recall

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Distribution Pattern

Nationwide and PR

Code Information

A3021 Exp 6/2/13 and L5011 exp 12/11/13

Other recalls by Lowlite Investments, Inc. D/B/A Olympia Pharmacy

  • D-725-2013 Class II — Doxapram 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL (May 29, 2013)
  • D-733-2013 Class II — Gentamicin 300 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL (May 29, 2013)
  • D-759-2013 Class II — Metoclopramide 5 mg/ml Injection,compounded by Olympia Pharmacy, Orlando, FL (May 29, 2013)
  • D-717-2013 Class II — Detomidine 10 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL (May 29, 2013)
  • D-794-2013 Class II — Voriconazole 5% Ophthalmic drop compounded by Olympia Pharmacy, Orlando, FL (May 29, 2013)
  • D-789-2013 Class II — Vitamin 15 (HEMO15) Injection, compounded by Olympia Pharmacy, Orlando, FL (May 29, 2013)
  • D-747-2013 Class II — L-ArGiNINE 200 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL (May 29, 2013)
  • D-784-2013 Class II — Tacrolimus (0.02% and 0.03%) drops, compounded by Olympia Pharmacy, Orlando, FL (May 29, 2013)
  • D-710-2013 Class II — Calcium Gluconate 23%, compounded by Olympia Pharmacy, Orlando, FL (May 29, 2013)
  • D-767-2013 Class II — Pento-Gluc 200 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL (May 29, 2013)